Industry Research Reports
Home > Reports > Pharma & Healthcare > Antivirals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Antivirals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-01-24
Pages: 124 Pages
Report ld: 2332012
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Antivirals Market Size(US$)
CAGR 2024-2030
4.5%
Market Size,2030
USD 62,600
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 48,070 million
Market Forecast in 2030(Value)
US$ 62,600 million
CAGR
4.5%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global market for Antivirals was estimated to be worth US$ 44620 million in 2023 and is forecast to a readjusted size of US$ 62600 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
By Company
- Merck
- Johnson & Johnson
- Teva Pharmaceutical Industries
- GSK
- Mylan
- Gilead Sciences
- F. Hoffmann-La Roche
- Bristol-Myers-Squibb
- AbbVie
- Aurobindo Pharma
- Cipla
- Dr Reddy’s
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Generic
- Branded
Segment by Application
- HIV
- Hepatitis
- HSV
- Influenza
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Antivirals, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antivirals by region & country, by Type, and by Application.
The Antivirals market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivirals.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antivirals in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Antivirals Product Introduction
1.2 Global Antivirals Market Size Forecast
1.2.1 Global Antivirals Sales Value (2019-2030)
1.2.2 Global Antivirals Sales Volume (2019-2030)
1.2.3 Global Antivirals Sales Price (2019-2030)
1.3 Antivirals Market Trends & Drivers
1.3.1 Antivirals Industry Trends
1.3.2 Antivirals Market Drivers & Opportunity
1.3.3 Antivirals Market Challenges
1.3.4 Antivirals Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antivirals Players Revenue Ranking (2023)
2.2 Global Antivirals Revenue by Company (2019-2024)
2.3 Global Antivirals Players Sales Volume Ranking (2023)
2.4 Global Antivirals Sales Volume by Company Players (2019-2024)
2.5 Global Antivirals Average Price by Company (2019-2024)
2.6 Key Manufacturers Antivirals Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Antivirals Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antivirals
2.9 Antivirals Market Competitive Analysis
2.9.1 Antivirals Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Antivirals Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Generic
3.1.2 Branded
3.2 Global Antivirals Sales Value by Type
3.2.1 Global Antivirals Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antivirals Sales Value, by Type (2019-2030)
3.2.3 Global Antivirals Sales Value, by Type (%) (2019-2030)
3.3 Global Antivirals Sales Volume by Type
3.3.1 Global Antivirals Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Antivirals Sales Volume, by Type (2019-2030)
3.3.3 Global Antivirals Sales Volume, by Type (%) (2019-2030)
3.4 Global Antivirals Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 HIV
4.1.2 Hepatitis
4.1.3 HSV
4.1.4 Influenza
4.2 Global Antivirals Sales Value by Application
4.2.1 Global Antivirals Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antivirals Sales Value, by Application (2019-2030)
4.2.3 Global Antivirals Sales Value, by Application (%) (2019-2030)
4.3 Global Antivirals Sales Volume by Application
4.3.1 Global Antivirals Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Antivirals Sales Volume, by Application (2019-2030)
4.3.3 Global Antivirals Sales Volume, by Application (%) (2019-2030)
4.4 Global Antivirals Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Antivirals Sales Value by Region
5.1.1 Global Antivirals Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antivirals Sales Value by Region (2019-2024)
5.1.3 Global Antivirals Sales Value by Region (2025-2030)
5.1.4 Global Antivirals Sales Value by Region (%), (2019-2030)
5.2 Global Antivirals Sales Volume by Region
5.2.1 Global Antivirals Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Antivirals Sales Volume by Region (2019-2024)
5.2.3 Global Antivirals Sales Volume by Region (2025-2030)
5.2.4 Global Antivirals Sales Volume by Region (%), (2019-2030)
5.3 Global Antivirals Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Antivirals Sales Value, 2019-2030
5.4.2 North America Antivirals Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Antivirals Sales Value, 2019-2030
5.5.2 Europe Antivirals Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Antivirals Sales Value, 2019-2030
5.6.2 Asia Pacific Antivirals Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Antivirals Sales Value, 2019-2030
5.7.2 South America Antivirals Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antivirals Sales Value, 2019-2030
5.8.2 Middle East & Africa Antivirals Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antivirals Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antivirals Sales Value
6.2.1 Key Countries/Regions Antivirals Sales Value, 2019-2030
6.2.2 Key Countries/Regions Antivirals Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Antivirals Sales Value, 2019-2030
6.3.2 United States Antivirals Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antivirals Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antivirals Sales Value, 2019-2030
6.4.2 Europe Antivirals Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antivirals Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antivirals Sales Value, 2019-2030
6.5.2 China Antivirals Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antivirals Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antivirals Sales Value, 2019-2030
6.6.2 Japan Antivirals Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antivirals Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antivirals Sales Value, 2019-2030
6.7.2 South Korea Antivirals Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antivirals Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antivirals Sales Value, 2019-2030
6.8.2 Southeast Asia Antivirals Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antivirals Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antivirals Sales Value, 2019-2030
6.9.2 India Antivirals Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antivirals Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Antivirals Product Offerings
7.1.5 Merck Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Information
7.2.2 Johnson & Johnson Introduction and Business Overview
7.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Johnson & Johnson Antivirals Product Offerings
7.2.5 Johnson & Johnson Recent Development
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Company Information
7.3.2 Teva Pharmaceutical Industries Introduction and Business Overview
7.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Teva Pharmaceutical Industries Antivirals Product Offerings
7.3.5 Teva Pharmaceutical Industries Recent Development
7.4 GSK
7.4.1 GSK Company Information
7.4.2 GSK Introduction and Business Overview
7.4.3 GSK Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GSK Antivirals Product Offerings
7.4.5 GSK Recent Development
7.5 Mylan
7.5.1 Mylan Company Information
7.5.2 Mylan Introduction and Business Overview
7.5.3 Mylan Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mylan Antivirals Product Offerings
7.5.5 Mylan Recent Development
7.6 Gilead Sciences
7.6.1 Gilead Sciences Company Information
7.6.2 Gilead Sciences Introduction and Business Overview
7.6.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Gilead Sciences Antivirals Product Offerings
7.6.5 Gilead Sciences Recent Development
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Company Information
7.7.2 F. Hoffmann-La Roche Introduction and Business Overview
7.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.7.4 F. Hoffmann-La Roche Antivirals Product Offerings
7.7.5 F. Hoffmann-La Roche Recent Development
7.8 Bristol-Myers-Squibb
7.8.1 Bristol-Myers-Squibb Company Information
7.8.2 Bristol-Myers-Squibb Introduction and Business Overview
7.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bristol-Myers-Squibb Antivirals Product Offerings
7.8.5 Bristol-Myers-Squibb Recent Development
7.9 AbbVie
7.9.1 AbbVie Company Information
7.9.2 AbbVie Introduction and Business Overview
7.9.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.9.4 AbbVie Antivirals Product Offerings
7.9.5 AbbVie Recent Development
7.10 Aurobindo Pharma
7.10.1 Aurobindo Pharma Company Information
7.10.2 Aurobindo Pharma Introduction and Business Overview
7.10.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Aurobindo Pharma Antivirals Product Offerings
7.10.5 Aurobindo Pharma Recent Development
7.11 Cipla
7.11.1 Cipla Company Information
7.11.2 Cipla Introduction and Business Overview
7.11.3 Cipla Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Cipla Antivirals Product Offerings
7.11.5 Cipla Recent Development
7.12 Dr Reddy’s
7.12.1 Dr Reddy’s Company Information
7.12.2 Dr Reddy’s Introduction and Business Overview
7.12.3 Dr Reddy’s Antivirals Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Dr Reddy’s Antivirals Product Offerings
7.12.5 Dr Reddy’s Recent Development
8 Industry Chain Analysis
8.1 Antivirals Industrial Chain
8.2 Antivirals Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antivirals Sales Model
8.5.2 Sales Channel
8.5.3 Antivirals Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Antivirals Market Trends
Table 2. Antivirals Market Drivers & Opportunity
Table 3. Antivirals Market Challenges
Table 4. Antivirals Market Restraints
Table 5. Global Antivirals Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antivirals Revenue Market Share by Company (2019-2024)
Table 7. Global Antivirals Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Antivirals Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Antivirals Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Antivirals Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Antivirals Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Antivirals
Table 13. Global Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Antivirals Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Antivirals Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Antivirals Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Antivirals Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Antivirals Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Antivirals Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Antivirals Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Antivirals Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Antivirals Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Antivirals Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Antivirals Price by Type (2019-2024) & (USD/MT)
Table 27. Global Antivirals Price by Type (2025-2030) & (USD/MT)
Table 28. Global Antivirals Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Antivirals Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Antivirals Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Antivirals Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Antivirals Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Antivirals Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Antivirals Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Antivirals Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Antivirals Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Antivirals Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Antivirals Price by Application (2019-2024) & (USD/MT)
Table 39. Global Antivirals Price by Application (2025-2030) & (USD/MT)
Table 40. Global Antivirals Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Antivirals Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Antivirals Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Antivirals Sales Value by Region (2019-2024) & (%)
Table 44. Global Antivirals Sales Value by Region (2025-2030) & (%)
Table 45. Global Antivirals Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Antivirals Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Antivirals Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Antivirals Sales Volume by Region (2019-2024) & (%)
Table 49. Global Antivirals Sales Volume by Region (2025-2030) & (%)
Table 50. Global Antivirals Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Antivirals Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Antivirals Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Antivirals Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Antivirals Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Antivirals Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Antivirals Sales Volume, (2025-2030) & (K MT)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Merck Antivirals Product Offerings
Table 61. Merck Recent Development
Table 62. Johnson & Johnson Company Information
Table 63. Johnson & Johnson Introduction and Business Overview
Table 64. Johnson & Johnson Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Johnson & Johnson Antivirals Product Offerings
Table 66. Johnson & Johnson Recent Development
Table 67. Teva Pharmaceutical Industries Company Information
Table 68. Teva Pharmaceutical Industries Introduction and Business Overview
Table 69. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Teva Pharmaceutical Industries Antivirals Product Offerings
Table 71. Teva Pharmaceutical Industries Recent Development
Table 72. GSK Company Information
Table 73. GSK Introduction and Business Overview
Table 74. GSK Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. GSK Antivirals Product Offerings
Table 76. GSK Recent Development
Table 77. Mylan Company Information
Table 78. Mylan Introduction and Business Overview
Table 79. Mylan Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Mylan Antivirals Product Offerings
Table 81. Mylan Recent Development
Table 82. Gilead Sciences Company Information
Table 83. Gilead Sciences Introduction and Business Overview
Table 84. Gilead Sciences Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Gilead Sciences Antivirals Product Offerings
Table 86. Gilead Sciences Recent Development
Table 87. F. Hoffmann-La Roche Company Information
Table 88. F. Hoffmann-La Roche Introduction and Business Overview
Table 89. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. F. Hoffmann-La Roche Antivirals Product Offerings
Table 91. F. Hoffmann-La Roche Recent Development
Table 92. Bristol-Myers-Squibb Company Information
Table 93. Bristol-Myers-Squibb Introduction and Business Overview
Table 94. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Bristol-Myers-Squibb Antivirals Product Offerings
Table 96. Bristol-Myers-Squibb Recent Development
Table 97. AbbVie Company Information
Table 98. AbbVie Introduction and Business Overview
Table 99. AbbVie Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. AbbVie Antivirals Product Offerings
Table 101. AbbVie Recent Development
Table 102. Aurobindo Pharma Company Information
Table 103. Aurobindo Pharma Introduction and Business Overview
Table 104. Aurobindo Pharma Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. Aurobindo Pharma Antivirals Product Offerings
Table 106. Aurobindo Pharma Recent Development
Table 107. Cipla Company Information
Table 108. Cipla Introduction and Business Overview
Table 109. Cipla Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Cipla Antivirals Product Offerings
Table 111. Cipla Recent Development
Table 112. Dr Reddy’s Company Information
Table 113. Dr Reddy’s Introduction and Business Overview
Table 114. Dr Reddy’s Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Dr Reddy’s Antivirals Product Offerings
Table 116. Dr Reddy’s Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Antivirals Downstream Customers
Table 120. Antivirals Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivirals Product Picture
Figure 2. Global Antivirals Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antivirals Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Antivirals Sales Volume (2019-2030) & (K MT)
Figure 5. Global Antivirals Sales Price (2019-2030) & (USD/MT)
Figure 6. Antivirals Report Years Considered
Figure 7. Global Antivirals Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Antivirals Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antivirals Revenue in 2023
Figure 10. Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Generic Picture
Figure 12. Branded Picture
Figure 13. Global Antivirals Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Antivirals Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Antivirals Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 16. Global Antivirals Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Antivirals Price by Type (2019-2030) & (USD/MT)
Figure 18. Product Picture of HIV
Figure 19. Product Picture of Hepatitis
Figure 20. Product Picture of HSV
Figure 21. Product Picture of Influenza
Figure 22. Global Antivirals Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Antivirals Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Antivirals Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 25. Global Antivirals Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Antivirals Price by Application (2019-2030) & (USD/MT)
Figure 27. North America Antivirals Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Antivirals Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Antivirals Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Antivirals Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Antivirals Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Antivirals Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Antivirals Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Antivirals Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Antivirals Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Antivirals Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Antivirals Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Antivirals Sales Volume (%), (2019-2030)
Figure 39. United States Antivirals Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Antivirals Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Antivirals Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Antivirals Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Antivirals Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Antivirals Sales Value by Application (%), 2023 VS 2030
Figure 45. China Antivirals Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Antivirals Sales Value by Type (%), 2023 VS 2030
Figure 47. China Antivirals Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Antivirals Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Antivirals Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Antivirals Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Antivirals Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Antivirals Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Antivirals Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Antivirals Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Antivirals Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Antivirals Sales Value by Application (%), 2023 VS 2030
Figure 57. India Antivirals Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Antivirals Sales Value by Type (%), 2023 VS 2030
Figure 59. India Antivirals Sales Value by Application (%), 2023 VS 2030
Figure 60. Antivirals Industrial Chain
Figure 61. Antivirals Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 4.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Antivirals market?
What was the global market size of Antivirals in 2030?
What is the annual compound growth rate of the global Antivirals market size from 2024 to 2030?
What was the global market size of Antivirals in 2024?
Related Reports
Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antivirals was estimated to be worth US$ 52040 million in 2025 and is projected to reach US$ 70510 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 140
USD 3950.00
(Single User License)
Global Antivirals Market Research Report 2026
The global Antivirals market was valued at US$ 52040 million in 2025 and is anticipated to reach US$ 70510 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 121
USD 2900.00
(Single User License)
Global Antivirals Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antivirals market size was US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 92
USD 4250.00
(Single User License)
Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antivirals was estimated to be worth US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 119
USD 3950.00
(Single User License)
Global Antivirals Market Research Report 2025
The global market for Antivirals was valued at US$ 50010 million in the year 2024 and is projected to reach a revised size of US$ 67770 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published Date: 2025-02-25
Pages: 90
USD 2900.00
(Single User License)
Global Antivirals Market Insights, Forecast to 2030
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Global Antivirals Market Research Report 2024
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published Date: 2024-01-16
Pages: 90
USD 2900.00
(Single User License)
Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antivirals was estimated to be worth US$ 52040 million in 2025 and is projected to reach US$ 70510 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-07-14
Pages: 140
USD 3950.00 (Single User License)Global Antivirals Market Research Report 2026
The global Antivirals market was valued at US$ 52040 million in 2025 and is anticipated to reach US$ 70510 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-04-27
Pages: 121
USD 2900.00 (Single User License)Global Antivirals Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antivirals market size was US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 92
USD 4250.00 (Single User License)Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antivirals was estimated to be worth US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 119
USD 3950.00 (Single User License)Global Antivirals Market Research Report 2025
The global market for Antivirals was valued at US$ 50010 million in the year 2024 and is projected to reach a revised size of US$ 67770 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published: 2025-02-25
Pages: 90
USD 2900.00 (Single User License)Global Antivirals Market Insights, Forecast to 2030
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)Global Antivirals Market Research Report 2024
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published: 2024-01-16
Pages: 90
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now